Traditional food logging apps offer feedback after the fact—Libre Assist offers help in-the-moment to inform mealtime decisions before every bite
Abbott, a leading healthcare company, unveiled Libre Assist, a groundbreaking feature within the Libre app designed to help the millions of people living with diabetes in the U.S. better understand how the foods they eat affect their glucose levels. Unlike traditional food logging apps that only give feedback after a meal is logged, Libre Assist helps people make informed mealtime decisions before they eat. Abbott is launching the new technology during CES 2026 in Las Vegas.
Health Technology Insights: Tolion Health AI Adds Dr. Gregory J. Moore to Board
For people living with diabetes, daily health decisions are constant, and food choices are among the most critical, especially for those managing their condition solely through lifestyle changes. The challenge is intensified by each person’s unique response to food, making every meal decision complex.
“The Libre Assist feature is a gamechanger for me,” said Shirley Bovshow, who lives with Type 2 diabetes and is one of the first to try Abbott’s new feature. “Traditional food logging apps left me guessing. With Libre Assist I can see how a meal might affect my glucose before I eat—especially helpful when dining out or trying new foods. It gives me tips to reduce the glucose impact and my Libre 3 Plus sensor confirms the outcome afterward. The Libre app has become a go-to tool for me.”
Health Technology Insights: Integrated Dermatology Appoints Jennifer Morgan as CFO
Libre Assist uses generative AI to predict how a food choice may affect a person’s glucose levels. It then offers actionable and personalized meal guidance to support in-the-moment decisions. After the meal, it leverages data from Abbott’s leading Libre CGM systems sensors to confirm the actual impact.
Libre Assist offers:
- In-the-moment meal guidance: Before eating, users simply snap a photo or enter a text description of their food. The algorithm then identifies the ingredients and predicts the meal’s potential glucose impact by displaying a color-coded rating: green for minor, yellow for moderate, and orange for major. Plus, it provides practical meal tips to help lower the potential glucose impact – like choosing plain Greek yogurt instead of flavored or eating leafy greens and proteins before starches.
- Powerful CGM integration: After a meal, Libre Assist shows the individual’s personal glucose data from their Libre CGM systems sensor to show how the meal actually affected their glucose. This personalized feedback helps individuals understand their body’s unique response to different food items, so they can make informed decisions in the future.
“People living with diabetes need more than apps that just log food and fall short of helping them with meal decisions,” said Marc Taub, vice president of technical operations for Abbott’s diabetes care business. “That’s why Abbott built Libre Assist – a free, and advanced predictive tool that delivers personalized meal guidance and works with our leading Libre technology to deliver real-time glucose insights. For the first time, people have smart, in-the-moment support right at their fingertips to make a confident choice every time they eat.”
Libre Assist can be accessed within the Libre app by clicking on the Insights tab on the bottom navigation.
About FreeStyle Libre:
Abbott continues to pioneer ground-breaking technology to support people living with diabetes. The company revolutionized diabetes care 10 years ago with its world-leading FreeStyle Libre continuous glucose monitoring portfolio, which is used by more than 7 million people across over 60 countries. People use Libre technology to see their glucose numbers in real-time, providing insights into how food, activity, or insulin impacts their glucose to help them make progress on their health goals. There is full or partial reimbursement for Libre systems in more than 40 countries
Health Technology Insights: Segmed Gains Independent HIPAA Compliance Clearance for Data
To participate in our interviews, please write to our HealthTech Media Room at info@intentamplify.com





